William L. Holman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
William L. Holman has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
James K Kirklin
4 shared publicationsBarry K Rayburn
3 shared publicationsCatarina I. Kiefe
From the *Birmingham VA Medical Center; †University of Alabama at Birmingham; ‡Alabama Quality Assurance Foundation; §UAB Center for Outcomes and Effectiveness Research and Education; and ∥Birmingham/Atlanta VA Geriatric Research, Education, and Clinical Center, Birmingham, AL; ¶Duke University Medical Center, Durham, NC; and #East Alabama Medical Center, Opelika, AL
3 shared publicationsDavid C McGiffin
3 shared publicationsEric D. Peterson
From the *Birmingham VA Medical Center; †University of Alabama at Birmingham; ‡Alabama Quality Assurance Foundation; §UAB Center for Outcomes and Effectiveness Research and Education; and ∥Birmingham/Atlanta VA Geriatric Research, Education, and Clinical Center, Birmingham, AL; ¶Duke University Medical Center, Durham, NC; and #East Alabama Medical Center, Opelika, AL
3 shared publications- Richard M. Allman
Geriatrics and Extended Care, Department of Veterans Affairs, Washington, DC
3 shared publications
Latest Publications
- 28 February 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 83 (2) , 509
Invited commentary
- 28 February 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 83 (2) , 509
Invited commentary
- 28 February 2006
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 81 (2) , 710-711
Invited commentary
- 28 February 2006
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 81 (2) , 710-711
Invited commentary
- 1 February 2006
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 81 (2) , e6-e8
Native Aortic Valve Insufficiency in Patients With Left Ventricular Assist Devices
- 1 February 2006
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 81 (2) , e6-e8
Native Aortic Valve Insufficiency in Patients With Left Ventricular Assist Devices
- 30 September 2005
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (3) , 948-949
Invited commentary
- 30 September 2005
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (3) , 948-949
Invited commentary
- 1 January 2004
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (1) , 99-109
Alabama Coronary Artery Bypass Grafting Project
This report describes the first round of results for Phase II of the Alabama CABG Project, a regional quality improvement initiative. Charts submitted by all hospitals in Alabama performing CABG (ICD-9 codes 36.10–36.20) were reviewed by a Clinical Data Abstraction Center (CDAC) (preintervention 1999–2000; postintervention 2000–2001). Variables that described quality in Phase I were abstracted for Phase II and data describing the new variables of β-blocker use and lipid management were collected. Data samples collected onsite by participating hospitals were used for rapid cycle improvement in Phase II. CDAC data (n = 1927 cases in 1999; n = 2001 cases in 2000) showed that improvements from Phase I in aspirin prescription, internal mammary artery use, and duration of intubation persisted in Phase II. During Phase II, use of β-blockers before, during, or after CABG increased from 65% to 76% of patients (P < 0.05). Appropriate lipid management, an aggregate variable, occurred in 91% of patients before and 91% after the educational intervention. However, there were improvements in 3 of 5 subcategories for lipid management (documenting a lipid disorder [52%–57%], initiating drug therapy [45%–53%], and dietary counseling [74%–91%]; P < 0.05). In Phase II, this statewide process-oriented quality improvement program added two new measures of quality. Achievements of quality improvement from Phase I persisted in Phase II, and improvements were seen in the new variables of lipid management and perioperative use of β-blockers.
- 1 January 2004
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (1) , 99-109
Alabama Coronary Artery Bypass Grafting Project
This report describes the first round of results for Phase II of the Alabama CABG Project, a regional quality improvement initiative. Charts submitted by all hospitals in Alabama performing CABG (ICD-9 codes 36.10–36.20) were reviewed by a Clinical Data Abstraction Center (CDAC) (preintervention 1999–2000; postintervention 2000–2001). Variables that described quality in Phase I were abstracted for Phase II and data describing the new variables of β-blocker use and lipid management were collected. Data samples collected onsite by participating hospitals were used for rapid cycle improvement in Phase II. CDAC data (n = 1927 cases in 1999; n = 2001 cases in 2000) showed that improvements from Phase I in aspirin prescription, internal mammary artery use, and duration of intubation persisted in Phase II. During Phase II, use of β-blockers before, during, or after CABG increased from 65% to 76% of patients (P < 0.05). Appropriate lipid management, an aggregate variable, occurred in 91% of patients before and 91% after the educational intervention. However, there were improvements in 3 of 5 subcategories for lipid management (documenting a lipid disorder [52%–57%], initiating drug therapy [45%–53%], and dietary counseling [74%–91%]; P < 0.05). In Phase II, this statewide process-oriented quality improvement program added two new measures of quality. Achievements of quality improvement from Phase I persisted in Phase II, and improvements were seen in the new variables of lipid management and perioperative use of β-blockers.
- 1 June 2003
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (6) , S48-S57
Infection in ventricular assist devices: prevention and treatment
- 1 June 2003
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (6) , S48-S57
Infection in ventricular assist devices: prevention and treatment
- 1 November 2002
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (11) , 1246-1249
Mechanical circulatory support for myocarditis: how much recovery should occur before device removal?
- 1 November 2002
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (11) , 1246-1249
Mechanical circulatory support for myocarditis: how much recovery should occur before device removal?
- 1 May 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (5) , 1489-1494
Treatment of end-stage heart disease with outpatient ventricular assist devices
- 1 May 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (5) , 1489-1494
Treatment of end-stage heart disease with outpatient ventricular assist devices
- 1 February 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (2) , 569-574
Ischemic preconditioning and Na+/H+ exchange inhibition improve reperfusion ion homeostasis.
- 1 February 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (2) , 569-574
Ischemic preconditioning and Na+/H+ exchange inhibition improve reperfusion ion homeostasis.
- 18 July 2001
- Published by Springer Nature in Intensive Care Medicine
- Vol. 27 (8) , 1245-1246
Mechanical circulatory support: expanding knowledge and experience in a challenging patient subset
- 18 July 2001
- Published by Springer Nature in Intensive Care Medicine
- Vol. 27 (8) , 1245-1246
Mechanical circulatory support: expanding knowledge and experience in a challenging patient subset